Eisai Co. Ltd.

Eisai Co. Ltd.
Stock Exchange Other OTC
EPS
$2
Market Cap
$24.21 B
Shares Outstanding
296.57 M
Public Float
-
Eisai Co. Ltd. ADR
Stock Exchange Other OTC
EPS
$2
Market Cap
$16.36 B
Shares Outstanding
296.57 M
Public Float
-
Eisai Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY221.12
Market Cap
JPY1.78 T
Shares Outstanding
296.57 M
Public Float
237.92 M

Profile

Address
4-6-10 Koishikawa
Tokyo Tokyo 112
Japan
Employees -
Website http://www.eisai.co.jp
Updated 07/08/2019
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs.

Financials

View All
Created with Highcharts 5.0.14Eisai Co. Ltd.Net Income. Fiscal year is April-March. All values JPY Millions.38 25138 25143 25443 25454 93354 93339 35939 35951 84551 84563 38663 386201420152016201720182019020k40k60k80k
Created with Highcharts 5.0.14Eisai Co. Ltd.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.599 490599 490548 465548 465547 922547 922539 097539 097600 054600 054642 834642 8342014201520162017201820190200k400k600k800k

Haruo Naito
Chief Executive Officer & Representative Director
Hirokazu Kanai
Director